I denne komparative undersøgelse mod en æg- deriveret influenzavaccine blev serumbeskyttelse *, sero- konvertering eller signifikant stigning ** og geometrisk middelværdi (GMR) for anti- HA antistof (målt ved hæmagglutination- inhibition- assay, HI) vurderet ifølge prædefinerede kriterier.
In this comparative trial against an egg-derived influenza vaccine the seroprotection rate*, seroconversion or significant increase rate** and the geometric mean ratio (GMR) for anti-HA antibody (measured by HI) were assessed according to predefined criteria.